Role of Matrix Metallopeptidase 12 in the Development of Hepatocellular Carcinoma
Role of Matrix Metallopeptidase 12 in the Development of Hepatocellular Carcinoma
复制标题
基质金属肽酶 12 在肝细胞癌发生中的作用
DOI:
10.1080/08941939.2019.1637975
复制
发表时间:
2019-07-15
影响因子:
1.9
通讯作者:
Lu, Jun
中科院分区:
文献类型:
--
作者:
Gao, Hengjun;Zhou, Xu;Lu, Jun
Abstract Objective The aim of this study was to investigate the role of matrix metallopeptidase 12 (MMP-12) in the development of hepatocellular carcinoma (HCC). Materials and Methods : A total of 343 HCC patients were retrospectively analyzed. MMP-12 expression was detected by immunohistochemical staining and the correlation between MMP-12 expression and clinical features was analyzed. Serum interleukin-6 (IL-6) and IL-10 levels were detected by an enzyme-linked immunosorbent assay (ELISA). Survival analysis was performed using the Kaplan–Meier method and PD-L1 expression in T cells was detected by flow cytometry. Results : MMP-12 expression in HCC tissues showed no correlation with age, gender, viral infection, cirrhosis, Child-Pugh score, alpha-fetoprotein levels, or Barcelona-Clinic Liver Cancer stage. However, higher levels of MMP-12 expression were correlated with increased tumor size, poorer tumor cell differentiation, higher TNM stage, and poorer prognosis. Moreover, MMP-12 expression was positively correlated with PD-L1 expression. Further analysis indicated that the regulation of PD-L1 expression by MMP-12 may occur through the IL-6-signaling pathway. Conclusions : Higher levels of MMP-12 expression indicated a poorer prognosis. PD-L1 expression was positively correlated with MMP-12 expression, indicating that MMP-12 may promote the development of HCC through the up-regulation of PD-L1.